Sequencing Inc.

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Sequencing Inc. - overview

Established

2017

Location

Pasadena, CA, US

Primary Industry

Biotechnology

About

Based in California, US, and founded in 2017 by its CEO Brandon Colby, Sequencing Inc. operates as a provider of open operating systems for DNA sequencing, storage, analysis, personalization, and application development. In November 2022, Sequencing Inc. raised USD 5 million in seed funding led by Lerer Hippeau Ventures, with participation from Correlation Ventures, Gaingels Syndicate, Global Founders Capital, Mucker Capital, Red Antler, LLC, Red Sea Ventures, and XRC Labs.


Sequencing Inc. offers a comprehensive DNA test kit that includes free, unlimited storage of DNA data as well as unique tools and enhanced reports that transform DNA data into clear solutions for better health. In addition, the company report provides personalized insights about health, wellness, and genealogy. The company plans to use the seed funding to advance its DNA technology and update its genome sequencing service.


Current Investors

Correlation Ventures, Lerer Hippeau Ventures, Mucker Capital

Primary Industry

Biotechnology

Sub Industries

Bioinformatics, Molecular Science, Genetics & Gene Therapy, Web Applications

Website

www.sequencing.com

Verticals

Big Data, HealthTech

Company Stage

Angel & Seed

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.